Symbol
MAZE on Nasdaq
Investment type
Equity / Common Stock, par value $0.001
Latest Disclosed Ownership
6.07M shares
Security Ownership
13.9%

Third Rock Ventures IV, L.P. ownership in Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE)

2025-05-09 - Third Rock Ventures IV, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.07M shares of Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE). This represents 13.9% percent ownership of the company.